摘要:
The invention relates to novel N-hydroxy-substituted 1,2,3,6-tetrahydropyridine and piperidine derivatives of formula (I) wherein A stands for hydrogen or halogen; alkoxy; cyano; phenyl; phenyl monosubstituted by halogen; benzyl; benzyl monosubstituted by halogen; 2-phenylethyl monosubstituted by halogen on the phenyl moiety; or 2-picolyl group; B represents hydrogen; alkoxy or nitro group; D represents hydrogen or halogen; or alkoxy group; or B and D together stand for a -CH=CH-CH=CH- group; R represents hydrogen; alkyl or phenyl group; G is hydrogen; I stands for hydrogen or hydroxy group; or G and I together represent a single chemical bond; E stands for hydrogen or halogen; alkoxy or trifluoromethyl group; and m is 0, 1 or 2, with the proviso that: m is 0 or 2, or both G and I mean hydrogen, when A stands for benzyl or halogen-monosubstituted benzyl group; and m is 1, when A stands for 2-picolyl group, as well as their acid addition salts. The invention further relates to pharmaceutical compositions containing these compounds as active ingredients as well as to a process for the preparation of compounds of formula (I) and their intermediates. The compounds of formula (I) are useful for enhancing the tolerance of mammals (including man) against hypoxic and/or ischaemic states as well as for treating the degenerative and functional disturbances arising from hypoxic and/or ischaemic insults.
摘要:
The invention relates to novel, optically active cis and trans 14-(N-substituted aminomethyl)eburnane derivatives of formula (I), wherein R1 stands for hydrogen, a C1-6alkyl or C2-6alkenyl group; R2 means a C1-6alkyl, C2-6alkenyl or a hydroxy-C1-6alkyl group; or R1 and R2 represent together with the adjacent nitrogen atom to which they are attached, a 5 to 7-membered saturated ring, optionally containing one oxygen atom and/or one optionally substituted nitrogen atom as heteroatom; and n is 2 or 3, as well as pharmaceutically acceptable salts of these compounds. The compounds of the invention possess an antioxidative (lipid peroxidation-inhibiting) effect and therefore, they are useful for treating diseases connected with lipid peroxidation, such as ischaemic intestinal diseases, myocardial ischaemia, ischaemic cerebrovascular disturbances as well as some diseases of connective tissues, e.g. rheumatoid arthritis. The compounds of the invention are also suitable for treating or preventing cognitive disorders.
摘要:
This invention relates to novel, therapeutically active oxazinoisoquinoline derivatives of formula (I), wherein R means hydrogen, a C1-4 alkyl, phenyl or phenyl-C1-4 alkyl group; one of R and R stands for a C1-4 alkoxy group and the other one represents a phenyl-C1-4 alkoxy group optionally substituted by a C1-4 alkyl group in the aromatic nucleus; and R stands for a phenyl group optionally substituted by a C1-4 alkyl group in the aromatic nucleus and their solvates, their individual optically active and geometric isomers and mixtures of isomers as well as acid additon salts thereof. The invention further relates to pharmaceutical compositions containing the above compounds and a process for their preparation. The compounds of formula (I) are capable of inhibiting the calcium uptake to brain cells and have a protective effect in hypobaric hypoxia. Thus, they are useful in the protection from brain injuries of hypoxic origin.
摘要:
The invention relates to novel tetrahydropyridine derivatives, a process for their preparation and pharmaceutical compositions containing such compounds as active agents. In formula (I), Ar means a phenyl group optionally mono- or polysubstituted, Ar means a phenyl group optionally substituted, R means a hydrogen atom or an alkyl group with 1-6 carbon atoms, n can be either 0 or 1 with the proviso that if n = 0 then R can only mean a hydrogen atom and Ar is in any case substituted.